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ommentary: Regression residual vs. Bayesian analysis of
edicinal ﬂoras
A recent paper in JEP proposed using Bayesian statistics rather
han regression-residual techniques to analyze medicinal ﬂoras
Weckerle, 2011). Since the paper directly critiques a method which
 developed, and which has been used by myself and many others
ince, I feel it is appropriate for me  to share a critique of the new
ethod.
In this paper, the authors propose to use Bayesian statistics to
nalyze a regional Italian medicinal ﬂora. The overall approach uses
amilies as the basic unit of analysis, and creates an n-tuple of pairs
f numbers, one pair for each family (128 of them in this case),
here the numbers are, ﬁrst, the number of species in the family
n the region, and second, the number of those species reportedly
sed as medicinals. When I ﬁrst attempted an analysis like this in
he 1970s (Moerman, 1979), the obvious ﬁrst thing to try was per-
entages. But that did not work well because there were a number
f small families with 1, 2 or 3 species, all or some of which were
sed medicinally, which thereby had very large percentages (1 of
, or 2 of 2, or 3 of 3, all rated 100% usage). These small but utilized
amilies swamped the much larger families (Asteraceae, Rosaceae,
tc.) that provided the bulk of medicinal plants. To control for family
ize, I decided to use regression analysis to address the issue.
I found this to be very satisfactory for a number of reasons. First,
he regression analysis gave a number of species that might be uti-
ized as medicines in each family if they were selected at random.
t the time, it was common for people to suggest indeed, that was
ust how these people had selected their plants: “they just tried
nything, and sometimes they got lucky” was the tone of many
riters. This analysis of mine, showing some very large families
roducing the bulk of the medicinal plants, while other really large
amilies (Poaceae, Cyperaceae, Orchidaceae) did not, certainly sank
hat silly idea.
It is the case that medicinal plant data that I was analyzing do not
eet all the criteria of a regression analysis as detailed by Bennett
nd Husby (2008).  But ordinarily, regression analysis is done on a
ample drawn from a larger population. In most of the cases where
eople use such an analysis on medicinal plants, the assumption
more or less legitimate depending on the circumstances) is that
he data are not a sample, but a census of all medicinal plants used,
nd a full ﬂora listing all the plants available to the people being
tudied. The last edition of my  database of native American plant
se (Moerman, 1998) was published 13 years ago. Since that time I
ave paid careful attention to subsequently published instances of
ative American plant uses; I have in that time found about a dozen
nstances of utilized plants not mentioned already in the database.
dding a dozen uses to 47,000 items representing 3618 species will
ot change anything.
But in addition to the predicted number of species, the regres-
ion analysis also pointed to the residual; that is, the difference
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Open access under CC BY-NC-ND license.between the predicted value and the actual value. These gave a
clear array of numbers showing precisely which families produced
more medicinal plants, and which produced less, than randomness
would predict.
These results were fascinating and, I believe, unprecedented.
They not only answered once and for all the assertion that indige-
nous peoples’ plant use was  random, it raised a number of
additional new ethnobotanical questions, like, “Why sunﬂowers,
and not grasses,” and a range of similar ones. The analysis allowed
a fascinating comparison of food plants and drug plants which
overlap in curious and unanticipated ways, and pointed out the sig-
niﬁcance of “apparency” in the selection of medicinals, and many
others as well. And they offered a way to compare widely separated
peoples’ medicinal plant choices.
In addition, and this is perhaps most important, although regres-
sion analysis was  more complicated than percentages, it was not
difﬁcult to explain, and many people who were up until then
unaware of the possible value of a mathematical approach to eth-
nobotanical issues realized this was  a useful and interesting way
to proceed. The evidence of this is everywhere in ethnobotanical
journals where regression analyses are frequently parts of papers
from around the world, and in fascinating comparative analyses.
For example, the most recent issue of JEP – which appeared in my
mailbox two days before I wrote the ﬁrst version of this commen-
tary – has a fascinating comparison of the medicinal ﬂoras of Nepal,
New Zealand and the South African Cape (Saslis-Lagoudakis et al.,
2011) using regression residual analysis (they also report Bennett
and Huseby’s binomial values, but do not make much of them).
Why are the authors of the paper under review unhappy with
regression residual analysis? They argue that such an analysis is
“biased towards large plant families. This is because the resid-
ual of a relatively small plant family (e.g. n = 10) is maximally
10, while a relatively large plant family (e.g. n = 100) may  get a
residual of up to 100. Nonetheless, in the regression analysis all
plant families are lumped together pretending that small fami-
lies may  achieve residuals with the same order of magnitude as
those of large families. (p. nn)”
This is simply wrong. No family can get a residual equal the
size of the family unless the predicted value for the family were
zero, and the actual value were 10 (one calculates the residual by
subtracting the predicted value from the actual value). The only
way the predicted value could be zero would be in a culture which
utilized no medicinal plants, in which case the actual value would
be zero (in such a culture, the actual values and the predicted values
would all be zero). In the Campagna ﬂora, family sizes range from
1 to 253, and residuals vary from 18.4 to −17.9.
Of course large families may produce larger numbers of medic-
inal species than smaller ones (although it is very rare to ﬁnd large
families with more than 20–30% medicinal; that is, the residuals for
large families are never more than about 20, not “100” as alleged in
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Table  1
Comparison of bottom seven families in Weckerle et al.’s Bayesian analysis, and the
author’s regression analysis.
Bayes Regression
Fabaceae Geraniaceae
Amaranthaceae Amaranthaceae
Geraniaceae Cyperaceae
Cyperaceae Fabaceae
Poaceae Orchidaceae
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Orchidaceae Poaceae
he quotation above). But the whole point of the analysis is to show
hat many very large families may  produce no medicinal species
t all. Indeed, anyone interested in the smaller families, or partic-
lar smaller families, can easily examine them in context and in
erspective by eliminating the larger families in any way they pre-
er (calling them outliers), and repeating the regression residual
nalysis.
It is indeed the case that in most ﬂoras, a relatively small number
f relatively large plant families produce the great bulk of medicinal
lants. This is not the result of some statistical trick, rather it is
he result of generations of human beings studying nature, ﬁnding
mportant and helpful plants, and applying them to self or other in
he presence of illness, hunger, or the desire for color, beauty, or
tructure.
There is, then, a very good reason to privilege large families,
ecause that is where the medicinal plants are. To show this, I
arried out a standard regression residual analysis of the data pre-
ented by Weckerle et al. In their analysis, they look at the top 14
amilies as being the most productive of medicinal plants. However,
hose families contain, respectively, 261 species and 109 medicinal
pecies. This is 12% of the overall ﬂora, and 25% of the medici-
al ﬂora. In my  regression residual analysis of their data, the top
4 families contain, respectively, 822 species and 228 medicinal
pecies. This is 36% of the overall ﬂora, and 54% of the medici-
al species. And, not surprisingly, in the regression analysis, the
edicinal ﬂora looks remarkably like the medicinal ﬂoras of other
orthern hemisphere cultures (Moerman et al., 1999).
The bottom 7 families are the same in both analyses, with the
rder slightly varying (Table 1).
This Bayesian analysis does not clearly describe the medicinal
ora (although it does a pretty good job describing the part of
he ﬂora which does not provide many medicinals)! It dramati-
ally privileges small families and ignores important large ones.
ndeed, the correlation between the percentage of plants used and
he “Inf.” shown in Appendix A is 0.804 (“Inf.” is the abbreviation
or “inferior 95% probability margin”). The correlation of percentarmacology 139 (2012) 693– 694
used with regression residuals is 0.29. We can learn very nearly as
much about this dataset with an analysis of percentages as we can
with all these elaborate mathematics (because, like the Bayesian
analysis, percentages privilege small families).
The ﬁnal problem here is the unnecessary complexity of
Bayesian analysis. I have studied a lot of mathematics in my life,
and I have not a clue what Section 2.4 is about. I know what the
assumptions are in a regression residual analysis; but I have not
any idea what they are here. The ﬁgures are as obscure as the text.
It is the case that even avowed Bayesian aﬁcionados (like
Andrew Gelman) have serious questions about the approach. I
encourage everyone to read this article, and the debate it generated
(Gelman, 2008).
From my perspective, regression analysis is a simple tool which
offers anyone the opportunity to analyze an ethnobotanical dataset,
and understand what is happening.
To see the spreadsheet which compares the Bayesian, regres-
sion, and percentage analyses, click on this link, or paste it into
your browser.
http://www-personal.umd.umich.edu/∼dmoerman/Campagna.
xls
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